Rigel Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2024
Total Assets: $164.0M
Liabilities Breakdown FY2024
Total Liabilities: $160.7M
Asset Breakdown
Total Assets: $164.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $56.7M | 34.6% |
| Accounts Receivable | $41.6M | 25.4% |
| Inventory | $6.0M | 3.7% |
| Property, Plant & Equipment | $92.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $27.1M | 16.5% |
| Other Assets | $32.4M | 19.8% |
Liabilities Breakdown
Total Liabilities: $160.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.3M | 2.1% |
| Long-Term Debt | $60.0M | 37.3% |
| Other Liabilities | $97.3M | 60.6% |